SCHEMBL16849996

SCHEMBL16849996

COC(=O)CCCO[C@@H]1OC(CO[C@H]2OC(COC(C)=O)[C@@H](C)[C@H](C)C2OC(=O)c2ccccc2)[C@@H](C)[C@H](C)C1OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ NT5E P21589 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ TNF P01375 2/20 0.37
▸ TACR1 P25103 2/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SSTR2 P30874 3/20 0.35
▸ SSTR3 P32745 3/20 0.35
▸ SSTR5 P35346 3/20 0.35
▸ SSTR1 P30872 1/20 0.35
▸ SSTR4 P31391 1/20 0.35
▸ FGF2 P09038 1/20 0.35
▸ MDK P21741 1/20 0.35
▸ MCHR1 Q99705 2/20 0.35
▸ LGALS8 O00214 1/20 0.35
▸ SELP P16109 2/20 0.35
▸ PAX8 Q06710 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16062799 0.92 NT5E (0.39) NT5ETNFTACR1SSTR2SSTR3
SCHEMBL21537940 0.87 LMNA (0.42) LMNAKMT2ANT5EPOLBTNF
SCHEMBL16062800 0.87 LGALS8 (0.41) NT5ETACR1SSTR2SSTR3SSTR5
SCHEMBL16062802 0.87 SELP (0.38) LMNAKMT2ANT5ETNFTACR1
SCHEMBL26443696 0.87 MEN1 (0.41) LMNAKMT2APOLBTNFALDH1A1
SCHEMBL16062804 0.86 NT5E (0.38) NT5ETNFTACR1SSTR2SSTR3
SCHEMBL16062803 0.83 NT5E (0.36) NT5ETNFTACR1SSTR2SSTR3
SCHEMBL16062805 0.83 NT5E (0.36) NT5ETNFTACR1SSTR2SSTR3
SCHEMBL16062807 0.82 NT5E (0.36) NT5ETNFTACR1SSTR2SSTR3
SCHEMBL16062797 0.81 KDM4E (0.39) LMNATACR1ALDH1A1SSTR2SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493498-B2 Oligosaccharide-protein conjugates GENZYME CORPORATION (US) 2016-11-15 — — US disclosed
US-20150175643-A1 OLIGOSACCHARIDE-PROTEIN CONJUGATES GENZYME CORPORATION 2015-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175643-A1 OLIGOSACCHARIDE-PROTEIN CONJUGATES MAN2B1, GAA, GBA1 LMNA 2259/4885KMT2A 3781/4885NT5E 2722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback